Market Voices: Lilly's new obesity pill, NYSE owner eyes crypto firm
Source: SeekingAlpha
2025-12-18 13:22:23 ET
More on Eli Lilly, Intercontinental Exchange
- Eli Lilly: Short-Term Upside Exhausted (Rating Downgrade)
- Eli Lilly: The Right Long-Term Strategy
- Eli Lilly Further Cements Itself As The King Of Weight Loss
- Medicare-negotiated drug prices to halve out-of-pocket costs next year: report
- Eli Lilly obesity pill offers superior weight maintenance after injectable GLP-1s
Read the full article on Seeking Alpha
For further details see:
Market Voices: Lilly's new obesity pill, NYSE owner eyes crypto firm
Chugai Pharmaceutical
NASDAQ: CHGCF
CHGCF Trading
1.92% G/L:
$61.2525 Last:
411 Volume:
$61.2525 Open:
